微创心脏手术后加速康复结合零ICU理念的倾向性评分匹配分析
本研究比较微创二尖瓣手术患者接受ERMICS加速康复方案(零ICU理念,术后直接转普通病房)与标准治疗的安全性和临床疗效。2021至2023年共纳入611例(标准治疗566例,ERMICS 45例),2:1倾向性评分匹配后135例(标准治疗90例,ERMICS 45例)。
要点
- ERMICS组术后机械通气时间、疼痛评分和住院时间显著低于标准治疗组。
- 术后并发症发生率两组无显著差异,支持零ICU理念的临床推广。
核心结论
- ERMICS零ICU理念在微创二尖瓣手术中安全,且显著缩短术后机械通气时间和住院时间。
- 术后并发症与标准治疗无差异,支持该加速康复路径的临床应用。
研究设计与样本
- 回顾性队列研究,纳入2021至2023年因原发性重度二尖瓣反流行微创二尖瓣手术的患者。
- 共611例(标准治疗566例 vs ERMICS 45例),行2:1倾向性评分匹配后135例(标准治疗90例 vs ERMICS 45例)。
- ERMICS组手术当日转入普通病房而非ICU(零ICU概念)。
- 主要终点为安全性(死亡、卒中)、术后机械通气时间和住院时间。
主要发现
- ERMICS组术后机械通气时间显著更低(P=0.018,OR<0.01,CI<0.001)。
- ERMICS组术后疼痛显著更低(P=0.005,OR=0.36,CI 0.18-0.74)。
- ERMICS组住院时间显著更短(P=0.049,OR=0.28,CI 0.08-0.98)。
- 术后并发症两组无差异。
临床怎么用
- 对于原发性重度二尖瓣反流行微创二尖瓣手术的患者,可考虑ERMICS零ICU加速康复路径。
- 该路径可缩短术后机械通气时间和住院时间,且不增加术后并发症风险。
局限性
- ERMICS组样本量较小(匹配后45例),可能影响统计效能和结果的普遍性。
- 为单中心回顾性研究,存在选择偏倚可能,尽管采用了倾向性评分匹配。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
OBJECTIVES: This study investigates our enhanced recovery after minimally invasive cardiac surgery program "enhanced recovery after minimally invasive cardiac surgery" (ERMICS) following a 'Zero ICU' concept compared to standard-of-care treatment in terms of safety and clinical efficacy. METHODS: All patients who underwent minimally invasive mitral valve surgery for primary severe mitral valve regurgitation between 2021 and 2023 were included. Propensity score matching (2:1) was performed between patients who received standard-of-care treatment and those who underwent ERMICS. Patients treated with the ERMICS approach were transferred to the peripheral ward instead of the intensive care unit on the day of surgery (Zero ICU). Separate primary end-points were safety (mortality, stroke), postoperative ventilation time and hospital length of stay. RESULTS: A total of 611 patients (566 standard of care vs 45 ERMICS) were included in the study. After 2:1 matching, the cohort comprised 135 patients (90 standard of care vs 45 ERMICS) and were well balanced in terms of pre- and intraoperative variables. Thirty-day mortality was 0% in both groups. Postoperative ventilation time [P = 0.018, odds ratio (OR) < 0.01, confidence interval (CI) < 0.001], postoperative pain (P = 0.005, OR = 0.36, CI 0.18-0.74) and hospital length of stay (P = 0.049, OR = 0.28, CI 0.08-0.98) was significantly lower in ERMICS patients, while postoperative complications did not differ. CONCLUSIONS: Our ERMICS 'Zero ICU' concept is safe and leads to significantly shorter postoperative ventilation time and hospital length of stay for patients undergoing minimally invasive mitral valve surgery for primary severe mitral valve regurgitation.
引用
- Pitts L, Dini M, Goecke S, et al. Enhanced recovery after minimally invasive cardiac surgery following a zero ICU concept-a propensity score-matched analysis. Eur J Cardiothorac Surg. 2024. PMID: 39673742. doi:10.1093/ejcts/ezae439
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。